ReachMD

Episodes 1-15 of 116

• • 

    

    Sara Tolaney MD, MPH

    Peer

  1

  

  RestartResume

  New Treatment Strategies for HER2+ Breast Cancer: The Latest from ASCO

• • 

    

    Sara Tolaney MD, MPH

    Peer

  1

  

  RestartResume

  Emerging Roles for Immunotherapy in HER2+ Breast Cancer

• • 

    

    Matt Birnholz, MD

    Peer

  • 

    

    Luka Dobovisek, MD

    Peer

  2

  

  RestartResume

  Investigating the Impact of Cannabidiol on Breast Cancer Cell Viability

• • 

    

    Matt Birnholz, MD

    Peer

  • 

    

    Slavica Janeva, MD

    Peer

  3

  

  RestartResume

  Monitoring Adjuvant Chemotherapy in Elderly Women with Triple Negative Breast Cancer

• • 

    

    Paul Doghramji, MD

    Peer

  • 

    

    Megan Arnot

    Peer

  5

  

  RestartResume

  Investigating the Link Between Sexual Activity & Menopause Onset

• • 

    

    C. Kent Osborne, MD

    Peer

  2

  

  RestartResume

  A Look at What’s Ahead in Breast Cancer Care

• • 

    

    Matt Birnholz, MD

    Peer

  • 

    

    Stephen Hiscox, PhD

    Peer

  3

  

  RestartResume

  Linking Statins to the Suppression of Aggressive Phenotypes of Triple-Negative Breast Cancer Cells

• • 

    

    Matt Birnholz, MD

    Peer

  • 

    

    Nadine Tung, MD

    Peer

  2

  

  RestartResume

  What to Look for When Testing for Hereditary Breast Cancer

• • 

    

    Matt Birnholz, MD

    Peer

  • 

    

    Daniela Rosa, MD

    Peer

  1

  

  RestartResume

  The Effects of Dietary Interventions After Early Breast Cancer Treatment

• • 

    

    Matt Birnholz, MD

    Peer

  • 

    

    Lauren Nye, MD

    Peer

  3

  

  RestartResume

  New Perspectives on the Impact of Omega 3 Supplements on Breast Cancer Risk

• • 

    

    Matt Birnholz, MD

    Peer

  • 

    

    Marina Kaplan, PhD

    Peer

  7

  

  RestartResume

  An Outlier Survivor’s Story: Confronting Systemic Barriers in Breast Cancer Care

• • 

    

    Matt Birnholz, MD

    Peer

  • 

    

    Dawn L. Hershman, MD, MS

    Peer

  1

  

  RestartResume

  The Steep Toll of Endocrine Therapy on Breast Cancer Patients

• • 

    

    Jenn Simmons, MD

    Peer

  • 

    

    Susan Domchek, MD

    Peer

  1

  

  RestartResume

  Genetic Testing for Hereditary Breast & Ovarian Cancers: What the Guidelines Say

• • 

    

    William J. Gradishar MD, FASCO, FACP

    Peer

  2

  

  RestartResume

  Lynn Sage Breast Cancer Symposium: What It Is & What to Expect in 2019

• • 

    

    William J. Gradishar MD, FASCO, FACP

    Peer

  1

  

  RestartResume

  Lessons from the Lynn Sage Breast Cancer Symposium: Conference Highlights

• 1
• 2
• 3
• …
• 7
• 8
• Next